Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Association of estrogen receptor-alpha A908G (K303R) mutation with breast cancer risk

Abbasi, Sakineh ; Rasouli, Mina ; Nouri, Mehrnaz LU and Kalbasi, Samira (2013) In International Journal of Clinical and Experimental Medicine 6(1). p.39-49
Abstract
Genetic mutations in premalignant breast lesions may have a role in malignancy progression or influence the behavior of subsequent disease. A point mutation in estrogen receptor-alpha (ER-&ALPHA) as A908G (Lys303 -> Arg) was originally involved to hypersensitive to estrogen breast hyperplasia. We detected this mutation among Iranian women with invasive breast cancer. A population-based case-control study was conducted in 150 newly diagnosed invasive breast cancer and 147 healthy control individuals controls to screen for presence of the ER-alpha A908G mutation by using single-strand conformation polymorphism (SSCP) analysis and 33Pcycle DNA sequencing. We detected the 10.7% ER-alpha A908G mutation in the form of heterozygote... (More)
Genetic mutations in premalignant breast lesions may have a role in malignancy progression or influence the behavior of subsequent disease. A point mutation in estrogen receptor-alpha (ER-&ALPHA) as A908G (Lys303 -> Arg) was originally involved to hypersensitive to estrogen breast hyperplasia. We detected this mutation among Iranian women with invasive breast cancer. A population-based case-control study was conducted in 150 newly diagnosed invasive breast cancer and 147 healthy control individuals controls to screen for presence of the ER-alpha A908G mutation by using single-strand conformation polymorphism (SSCP) analysis and 33Pcycle DNA sequencing. We detected the 10.7% ER-alpha A908G mutation in the form of heterozygote genotype only among cancer patients (chi(2)=22.752, P=0.00). The allelic frequency of mutant allele AGG in codon 303 was significantly (chi(2)=29.709, P=0.001) higher in patients with the family history of breast cancer (28.9%) than those without the family history of breast cancer (1.9%). Our data suggest that ER-alpha codon 303 mutation is correlated with various aspects of breast cancer in Iran. ER-alpha genotype might represent a surrogate marker for predicting breast cancer developing later in life. (Less)
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Breast cancer, mutation, estrogen receptor, PCR-SSCP, lymph node, metastasis
in
International Journal of Clinical and Experimental Medicine
volume
6
issue
1
pages
39 - 49
publisher
e-Century Publishing
external identifiers
  • wos:000318543100005
  • scopus:84870372461
ISSN
1940-5901
language
English
LU publication?
yes
id
92cdf211-a1a2-4548-8668-bb9cad5bc3e9 (old id 3987155)
alternative location
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515972/
date added to LUP
2016-04-01 14:17:29
date last changed
2022-01-27 23:50:58
@article{92cdf211-a1a2-4548-8668-bb9cad5bc3e9,
  abstract     = {{Genetic mutations in premalignant breast lesions may have a role in malignancy progression or influence the behavior of subsequent disease. A point mutation in estrogen receptor-alpha (ER-&ALPHA) as A908G (Lys303 -> Arg) was originally involved to hypersensitive to estrogen breast hyperplasia. We detected this mutation among Iranian women with invasive breast cancer. A population-based case-control study was conducted in 150 newly diagnosed invasive breast cancer and 147 healthy control individuals controls to screen for presence of the ER-alpha A908G mutation by using single-strand conformation polymorphism (SSCP) analysis and 33Pcycle DNA sequencing. We detected the 10.7% ER-alpha A908G mutation in the form of heterozygote genotype only among cancer patients (chi(2)=22.752, P=0.00). The allelic frequency of mutant allele AGG in codon 303 was significantly (chi(2)=29.709, P=0.001) higher in patients with the family history of breast cancer (28.9%) than those without the family history of breast cancer (1.9%). Our data suggest that ER-alpha codon 303 mutation is correlated with various aspects of breast cancer in Iran. ER-alpha genotype might represent a surrogate marker for predicting breast cancer developing later in life.}},
  author       = {{Abbasi, Sakineh and Rasouli, Mina and Nouri, Mehrnaz and Kalbasi, Samira}},
  issn         = {{1940-5901}},
  keywords     = {{Breast cancer; mutation; estrogen receptor; PCR-SSCP; lymph node; metastasis}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{39--49}},
  publisher    = {{e-Century Publishing}},
  series       = {{International Journal of Clinical and Experimental Medicine}},
  title        = {{Association of estrogen receptor-alpha A908G (K303R) mutation with breast cancer risk}},
  url          = {{http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3515972/}},
  volume       = {{6}},
  year         = {{2013}},
}